Multiple system atrophy trials in China

In China 15 Also abroad 71

10 of 15 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 2/3Taking people
Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy
Where
Beijing, Hangzhou, Huzhou, Jiaxing, Nanning, Ningbo, Taizhou
Age
30 years to 80 years
People
150
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07518810
Early phase 1Taking people
Expansion Study of ALT001 in Patients With Multiple System Atrophy
Where
Beijing
Age
30 years to 75 years
People
60
Run by
yilong Wang
See details and how to joinNCT07476352
Early phase 1Taking people
The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System Atrophy-Cerebellar Type
Where
Beijing
Age
30 years to 75 years
People
20
Run by
yilong Wang
See details and how to joinNCT07514923
Phase 1Taking people
A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA
Where
Shanghai, Wuxi
Age
18 years and over
People
30
Run by
Synusight Biotech (Shanghai) Co., Ltd.
See details and how to joinNCT07604116
Phase 1Not yet taking people in China
A Prospective Exploratory Study of the Safety and Preliminary Efficacy of the α-Syn H21 Monoclonal Antibody in Patients With Multiple System Atrophy
Where
Shanghai
Age
45 years to 75 years
People
3
Run by
Ruijin Hospital
See details and how to joinNCT07774585
No phaseTaking people
Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
Where
Beijing
Age
30 years to 80 years
People
50
Run by
Peking University First Hospital
See details and how to joinNCT07570212
Phase 1Taking people
A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy
Where
Beijing
Age
30 years to 70 years
People
9
Run by
iRegene Therapeutics Co., Ltd.
See details and how to joinNCT07289477
Early phase 1Taking people
The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy
Where
Beijing
Age
30 years to 75 years
People
20
Run by
Beijing Tiantan Hospital
See details and how to joinNCT06765733
Phase 1Not yet taking people in China
hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases
Where
Beijing
Age
18 years to 80 years
People
120
Run by
Xuanwu Hospital, Beijing
See details and how to joinNCT06607900
No phaseNot yet taking people in China
Efficacy and Safety of Bilateral Cervical Lymphatic-Venous Anastomosis in the Treatment of Multiple System Atrophy
Where
Shanghai
Age
40 years to 70 years
People
46
Run by
Ruijin Hospital
See details and how to joinNCT07036939